Neuroone Medical Technologies is trading 6.9% up in pre-market at $2.17 after closing at $2.00 on August 26, 2026, with no verified company-specific catalyst identified.
- No verified company-specific announcement or filing dated August 27 has been identified; the latest major results were released August 13.
- The move may reflect continued speculative interest after recent earnings-related updates, but available evidence does not establish a direct cause.
- Broader Nasdaq strength provides limited additional context.